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ABSTRACT
10 A new approach to the synthesis of 4,5-disubstituted cyclopentenones is described. The strategy is based on the PausonKhand (PK) reaction
11 of norbornadiene and N-Boc-propargylamine as an alkyne with a masked leaving group, which can be eliminated at will. This approach to the
12 synthesis of 4,5-disubstituted cyclopentenones overcomes the problem of using the alkylation to introduce the R side chain. As an example,
13 prostane 13-epi-12-oxo-phytodienoic acid (13-epi-12-oxo-PDA) methyl ester was synthesized.
14
15 Cyclopentanic compounds are abundant in nature and
16 exhibit a wide range of structures and biological functions.
17 Among them, prostanes are one of the largest biologically
18 relevant classes of compounds.1 They are generated as a
19 product of the action of cyclooxygenases (COX) on fatty
20 acids from the phospholipid bilayer. The most common
21 substrate for this reaction cascade in the human body is
22 arachidonic acid, which gives rise to prostaglandins.2
23 A similar process occurs in plants, but linolenic acid is
24 the main substrate and the corresponding prostanes are
25 called phytoprostanes.2a,3 Most share a disubstituted cy-
26 clopentane ring with different degrees of oxidation as the
27 principal structural subunit. The 4,5-disubstituted cyclo-
28 pentenone fragment is present in prostanes A and J as in
29 the examples shown in Figure 1F1 .
30 A convenient strategy to synthesize complex cyclopen-
31 tenones consists of uncovering the enone functionality at
32 the last step through a retro-DielsAlder (r-DA) reaction.
33Griecopioneered thismethodusingdicyclopentadienederiv-
34atives (with endo-stereochemistry) as starting materials.4
35The intermolecular PausonKhand reaction (PKR)
36(a cobalt-catalyzed cycloaddition between an alkyne, an
37alkene, and CO to give a cyclopentenone) is particularly
38suited for the preparation of similar compounds, although
39with exo stereochemistry.5,6 The norbornene fragment
40of these PK adducts can be considered as a masked enone
41that also plays a fundamental stereodirecting role on the
Figure 1. Biologically relevant 4,5-disubstituted cyclopentenones.
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42 conjugate additions to the cycloadducts. The PKR of
43 norbornadiene (NBD) with a large variety of alkynes
44 provides tricyclic compounds, which, after chemical mod-
45 ifications, can experience r-DA reactions to afford the
46 desired cyclopentenones. The known asymmetric versions
47 of the intermolecular PKR7 add value to this approach,
48 which has been applied to the enantioselective total synth-
49 esis of Brefeldin A,8 the carbanucleosides Avacavir and
50 Carbovir,9 and prostanes dPPJ1 (I and II).
10 Although the
51 synthesis of chiral 4-substituted cyclopentenones or 5-alky-
52 lidenecyclopen-2-enones starting from the PK adduct of
53 NBD and trimethylsilylacetylene (IV) was successful,9,10
54 the introduction of a saturated R side chain to the carbonyl
55 (from III to II) was troublesome (Scheme 1S1 ). Although the
56 conjugate addition/desilylation to give IIIworks well,11 the
57 alkylation of these compounds producesmixtures of starting
58 material and alkylated and dialkylated products.12 To over-
59 come this problem, we planned the synthesis of the exocyclic
60 enonesV, which could undergo a second conjugate addition,
61 thus giving the desired precursors II. We envisaged the prep-
62 aration of enones V from PK adducts VI with a potential
63 leaving group X. Here we describe the synthesis of 4,5-dis-
64 ubstituted cyclopentenones via conjugate addition of exo-
65 methylene cyclopentenones followed by r-DA. For this pur-
66 pose, we developed a practical sequence for the asymmetric
67synthesis of these exocyclic enones via PK reaction ofN-Boc-
68propargyl amines. We also describe the application of our
69method to the enantioselective synthesis of 13-epi-12-oxo-
70phytodienoic acid (13-epi-12-oxo-PDA) methyl ester.
71We first chose phenyl propargyl thioether 1a as an
72alkyne with a potential leaving group, since we considered
73that sulfide oxidation could facilitate elimination. Phenyl
74propargyl ether 1b was also selected, since it could lead to
75the exocyclic enone by acidic treatment. Finally, we chose
76N,N-dimethyl, N-methyl-N-Boc, and N-Boc propargyl
77amine derivatives 1ce, because the elimination could be
78promoted by alkylation. The PK reaction of all of these
79alkynes 1ae with NBD under thermal conditions took
80place uneventfully, affording tricyclic cyclopentenones
812ae in satisfactory yields (Table 1 T1).
82With the PK adducts 2ae in hand, we studied con-
83jugate additions to this enones, using lithium dibutyl
84cuprate as the initial convenient reagent. Unexpectedly,
85treatment of adduct 2a bearing a thioether function with
86the cuprate at low temperature afforded the double addi-
87tion product 3a. Most probably, once the first conjugate
88addition is performed, the enolate intermediate evolves
89rapidly, even at low temperature, giving rise to the exo-
90cyclic enone. This enone would react in situ in a 1,4 addi-
91tion manner with an excess of reagent, thus providing 3a
92and diphenyldisulfide (Table 2 T2, entry 1). Propargyl alcohol
93derivative 2b and dimethylpropargylamine 2c behaved
94similarly to 2a, providing the double addition prod-
95uct 3a (Table 2 entries 2, 3). This unexpected result led
96us to address carbamate derivatives. Gratifyingly,
97neither the N-methyl-N-Boc-propargylamine 2d nor N-Boc-
98propargylamine 2e experienced the in situ elimination and
99afforded the expected conjugate addition products 4 and 5
100respectively (Table 2, entries 7, 8). Therefore, only adducts
101containing a Boc-protected amine did not undergo the
102process of double conjugate addition previously described.
103To test the generality of these two processes, we studied
104different reaction conditions on theses substrates. As
105before, compounds 2ac gave double addition of nitro-
106methane (entries 46) whereas Boc-protected propargyla-
107mine 2e afforded the 1,4-addition product 5b (Table 2,
108entry 9). Although disubstituted products 3 are not suita-
109ble for our present synthetic objectives, this tandem con-
110jugate addition/elimination/conjugate addition in one pot
111was remarkable and is currently being studied in more
Scheme 1. Retrosynthetic Analysis of 4,5-Disubstituted
Cyclopentenones via PKR
Table 1. PKR of Norbornadiene with Alkynes 1
entry X PK conditions product yield
1 SPh toluene, 60 C, 4 h 2a 40%
2 OPh toluene, 70 C, 4 h 2b 71%
3 NMe2 hexanes, 60 C, 3 h 2c 87%
4 NMeBoc toluene, 65 C, 24 h 2d 85%
5 NHBoc hexanes, 60 C, 3 h 2e 61%
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112 detail by our group. For our purposes, the PK adduct of
113 Boc-propargylamine 2e was selected as the most conveni-
114 ent substrate since the asymmetric PK reaction on this
115 alkyne had already been studied.13 A series of conjugate
116 addition reactions on compound 2e were subsequently
117performed using a variety of reaction conditions (lithium
118dialkyl cuprates,Grignard reagentswith copper(I) catalysis,
119nonorganometallic reagents, and photochemically acti-
120vated reactions), affording compounds 5ag (Table 2,
121entries 814) in moderate to excellent yields.
122Once we had prevented the spontaneous elimination
123of the potential leaving group in the reaction media, we
124next studied a procedure to promote this process at will in
125order to add a different fragment through a second con-
126jugate addition. Acidic deprotection of the carbamate in
127compounds 5, followed by treatment with CH3I/NaHCO3,
128afforded the desired exocyclic enones 6. Due to the relative
129instability of these enones, which dimerized slowly, they
130were immediately subjected to a second conjugate addition,
131affording compounds7 inmoderate togoodyields (Table 3 T3).
132Once the method had been stablished in racemic form,
133an enantioselective versionwas pursued. PNSO ligands have
134been used in the PKR of N-Boc-propargylamine 1e with
135tetramethylnorbornadiene.13 PNSO ligand 8 gave excellent
136diastereoselectivities (up to 17:1) during the formation of
137cobalt complex 9. The major diastereomer was purified by
138crystallization. Diastereomerically pure cobalt complex 9
139was subjected to a PK reaction with NBD under either
140thermal or N-oxide-promoted conditions, yielding the en-
141antiomerically enriched adduct 2e in 87 to 92% ee, depend-
142ing on the purity of the dicobalt complex used (Scheme 2 S2).
143To test our approach to the preparation of 4,5-disubsti-
144tuted cyclopentenones, we applied it to the enantioselective
145synthesis of 13-epi-12-oxo-PDAmethyl ester. 12-Oxo-phyto-
146dienoic acid (12-oxo-PDA) is a biosynthetic precursor of
147jasmonic acid via the allene oxide synthase pathway.14 Jas-
148monic acid is formed during events of cellular stress and is
149thought to regulateaspectsof fruit ripening, theproductionof
150viable pollen, and plant resistance to pathogens and insects,
151among other features. Several syntheses of epi-jasmonic acid
152have been developed,15 but only a few processes have been
153described to lead to 12-oxo-PDA and its more stable epimer
15413-epi-12-oxo-PDA.4a,16
155Our synthesis started from enantiomerically enriched PK
156adduct ()-2e, which was treated with the cuprate reagent
157derived from 8-iodo-1-tert-butyldimethylsilyloxyoctane
Table 2. Conjugate Additions on PK Adducts 2
aLow yield due to the volatility of the product.
Table 3. Elimination and Conjugate Addition of Compounds 5
ent. sm R conditions prod. R0 yield
1 5a Bu CH2=CH-MgBr,
CuI
7ad vinyl 30%a
2 5a Bu CH3NO2 TBAF 7ab CH2NO2 82%
3 5d vinyl Bu2CuLi 7db Bu 25%
a
aLow yield due to the volatility of the product.
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158 (tBuLi, CuI), to afford cyclopentanone 13 in 65% yield
159 (Scheme 3S3 ). The tert-butyl carbamate in 13 was then
160 deprotected with HCl/MeOH. Since the Boc group could
161 not be selectively deprotected over the TBS group, both
162 the amine and alcohol were reprotected17 with TBSCl/
163 Imidazole/DMAP. The resulting product was treated with
164 MeI/NaHCO3 in DMF without prior purification to
165 afford the exocyclic enone 12. The crude product of 12
166 was also used without previous purification. The cuprate
167 reagent required for the conjugate addition of a Z-1-
168 butenyl fragment was difficult to prepare. In 1979, Alexakis
169 et al. reported the preparation of lithium di-(Z-butenyl)
170 cuprate from ethyl lithium, copper iodide, and acetylene.18
171 However, in our hands this methodology was difficult to
172 reproduce due to the difficulty inmeasuring the amount of
173 acetylene. Therefore, we opted to explore alternative,more
174 robust, methodologies. We envisaged Z-1-bromobut-1-ene
175 as the ideal precursor of cis-butenyl lithium cuprate since the
176 corresponding bromide is readily accessible using Brevet’s
177 methodology.19 Metalation of the bromide at low tempera-
178 ture with tert-BuLi, followed by addition to a suspension
179 of usual copper salts (CuI, CuBr, CuBr 3 SMe2), gave, in
180 all cases, insoluble and unreactive reagents. Since our
181 attempts to form the lithium di-(Z-butenyl) cuprate failed,
182 a higher order cupprate20 was tested. The reagent prepared
183 from lithium 2-thienylcyanocuprate and (Z)-but-1-en-1-yl
184 lithium allowed the reliable preparation adduct 11 in a
185 remakable 34% overall yield over four steps. The silyl ether
186 in11was further transformed into the correspondingmethyl
187 ester 15 by standard transformations in nearly quantitative
188 yield. Final r-DA under Grieco’s conditions6 (maleic anhy-
189 dride and MeAlCl2 in anhydrous DCM) using microwaves
190 afforded thedesiredproduct.Weachievedanoverall yieldof
191 12% over 10 synthetic steps.
192In summary, here we described a new approach to 4,5-
193disubstituted cyclopentenones via an intermolecular PKR.
194We have solved the problem of the introduction of theR side
195chain by using an alkyne with a masked leaving group. This
196approach allowed the formation of a methylene cyclopenta-
197none on which to perform a second conjugate addition.
198Thus, the PK adduct of NBD and N-Boc-propargylamine
199(also available in optically active form) was found to be
200a suitable product for our purposes.We performed a series
201of conjugate additions of distinct nucleophiles on the
202PK adduct. The removal of the Boc group followed
203by per-methylation afforded the exocylic enone which
204could be further functionalized by conjugate addition.
205The synthetic potential of this approach is reflected by
206the enantioselective synthesis of 13-epi-12-oxo-PDA.
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Scheme 2. Enantioselective Version of PKR
of N-Boc-propargylamine
Scheme 3. Enantioselective Synthesis of 13-epi-12-oxo PDA
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